Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CGX1321 |
Trade Name | |
Synonyms | CGX-1321|CGX 1321 |
Drug Descriptions |
CGX1321 inhibits PORCN, which reduces Wnt signaling and may decrease cell proliferation (PMID: 29162747, PMID: 32213921). |
DrugClasses | WNT Inhibitor 16 |
CAS Registry Number | NA |
NCIT ID | C146853 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + CGX1321 + Encorafenib | CGX1321 Cetuximab Encorafenib | 0 | 1 |
CGX1321 | CGX1321 | 0 | 1 |
CGX1321 + Pembrolizumab | CGX1321 Pembrolizumab | 0 | 1 |